| [1] |
Matei Ș, Cutler SJ, Preda M, Dorobanțu M, Ilinca C, et al. 2018. The relationship between psychosocial status and hypertensive condition. Current Hypertension Reports 20(12):102 doi: 10.1007/s11906-018-0902-y |
| [2] |
Kondo T, Toyoshima H, Tsuzuki Y, Hori Y, Yatsuya H, et al. 2005. Familial aggregation and coaggregation of history of hypertension and stroke. Journal of Human Hypertension 19(2):119−25 doi: 10.1038/sj.jhh.1001788 |
| [3] |
Rigaud AS, Forette B. 2001. Hypertension in older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56(4):M217−M225 doi: 10.1093/gerona/56.4.M217 |
| [4] |
Chockalingam A, Campbell NR, George Fodor J. 2006. Worldwide epidemic of hypertension. Canadian Journal of Cardiology 22(7):553−55 doi: 10.1016/S0828-282X(06)70275-6 |
| [5] |
Guilbert JJ. 2003. The World Health Report 2002 - reducing risks, promoting healthy life. Education for Health 16(2):230 |
| [6] |
Haldar RN. 2013. Global brief on hypertension: silent killer, global public health crisis. Indian Journal of Physical Medicine and Rehabilitation 24:2 doi: 10.5005/ijopmr-24-1-2 |
| [7] |
Suematsu M, Suzuki H, Delano FA, Schmid-Schönbein GW, et al. 2002. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 9(4):259−76 doi: 10.1038/sj.mn.7800141 |
| [8] |
Shere A, Eletta O, Goyal H. 2017. Circulating blood biomarkers in essential hypertension: a literature review. Journal of Laboratory and Precision Medicine 2(12):99 doi: 10.21037/jlpm.2017.12.06 |
| [9] |
Tousoulis D, Papageorgiou N, Androulakis E, Paroutoglou K, Stefanadis C. 2010. Novel therapeutic strategies targeting vascular endothelium in essential hypertension. Expert Opinion on Investigational Drugs 19(11):1395−412 doi: 10.1517/13543784.2010.522989 |
| [10] |
Nitenberg A. 2006. Hypertension, endothelial dysfunction and cardiovascular risk. Archives Des Maladies Du Coeur et Des Vaisseaux 99(10):915−21 |
| [11] |
Harvey A, Montezano AC, Touyz RM. 2015. Vascular biology of ageing-Implications in hypertension. Journal of Molecular and Cellular Cardiology 83:112−21 doi: 10.1016/j.yjmcc.2015.04.011 |
| [12] |
Spescha RD, Glanzmann M, Simic B, Witassek F, Keller S, et al. 2014. Adaptor protein p66Shc mediates hypertension-associated, cyclic stretch-dependent, endothelial damage. Hypertension 64(2):347−53 doi: 10.1161/HYPERTENSIONAHA.113.02129 |
| [13] |
Touyz RM, Briones AM. 2011. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertension Research 34(1):5−14 doi: 10.1038/hr.2010.201 |
| [14] |
Sinha N, Dabla PK. 2015. Oxidative stress and antioxidants in hypertension-a current review. Current Hypertension Reviews 11(2):132−42 doi: 10.2174/1573402111666150529130922 |
| [15] |
Jasiewicz M, Knapp M, Waszkiewicz E, Ptaszynska-Kopczynska K, Szpakowicz A, et al. 2015. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine 76(2):187−92 doi: 10.1016/j.cyto.2015.06.018 |
| [16] |
Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, et al. 2015. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Canadian Journal of Cardiology 31(5):631−41 doi: 10.1016/j.cjca.2015.02.008 |
| [17] |
Hirsch AT. 2003. Vascular disease, hypertension, and prevention: "from endothelium to clinical events". Journal of the American College of Cardiology 42(2):377−79 doi: 10.1016/S0735-1097(03)00747-2 |
| [18] |
Nathan C. 2002. Points of control in inflammation. Nature 420:846−52 doi: 10.1038/nature01320 |
| [19] |
Kacimi R, Karliner JS, Koudssi F, Long CS. 1998. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circulation Research 82(5):576−86 doi: 10.1161/01.res.82.5.576 |
| [20] |
Qi G, Jia L, Li Y, Bian Y, Cheng J, et al. 2011. Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent. Cardiovascular Toxicology 11(2):157−67 doi: 10.1007/s12012-011-9109-z |
| [21] |
Pereda J, Sabater L, Cassinello N, Gómez-Cambronero L, Closa D, et al. 2004. Effect of simultaneous inhibition of TNF-α production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Annals of Surgery 240(1):108−16 doi: 10.1097/01.sla.0000129343.47774.89 |
| [22] |
Södergren A, Karp K, Boman K, Eriksson C, Lundström E, et al. 2010. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Research & Therapy 12:R158 doi: 10.1186/ar3116 |
| [23] |
Lu RL, Hu FL, Xia T. 2010. Activity-guided isolation and identification of radical scavenging components in Gao-Cha tea. Journal of Food Science 75(8):H239−H243 doi: 10.1111/j.1750-3841.2010.01804.x |
| [24] |
Bock K, Faurschou laCour N, Jensen SR, Nielsen BJ. 2010. The structure of acertannin. Phytochemistry 19(9):2033 doi: 10.1016/0031-9422(80)83034-2 |
| [25] |
Hatano T, Hattori S, Ikeda Y, Shingu T, Okuda T. 1990. Gallotannins having a 1,5-anhydro-D-glucitol core and some ellagitannins from Acer species. Chemical & Pharmaceutical Bulletin 38(7):19025 doi: 10.1248/CPB.38.1902 |
| [26] |
Bate-Smith EC. 1978. Systematic aspects of the astringent tannins of Acer species. Chemical & Pharmaceutical Bulletin 17(11):1945−48 doi: 10.1016/S0031-9422(00)88739-7 |
| [27] |
Choi YH, Han SS, Lee HO, Baek SH. 2005. Biological Activity of Bioactive Components from Acer ginnala Max. Bulletin of the Korean Chemical Society 26(9):1450−52 doi: 10.5012/bkcs.2005.26.9.1450 |
| [28] |
González-Sarrías A, Li L, Seeram NP. 2012. Effects of maple ( Acer) plant part extracts on proliferation, apoptosis and cell cycle arrest of human tumorigenic and non-tumorigenic colon cells. Phytotherapy Research 26(7):995−1002 doi: 10.1002/ptr.3677 |
| [29] |
Ogawa A, Miyamae Y, Honma A, Koyama T, Yazawa K, et al. 2011. Pycnalin, a new α-glucosidase inhibitor from Acer pycnanthum. Chemical & Pharmaceutical Bulletin 59(5):672−75 doi: 10.1248/cpb.59.672 |
| [30] |
Honma A, Koyama T, Yazawa K. 2011. Anti-hyperglycaemic effects of the Japanese red maple Acer pycnanthum and its constituents the ginnalins B and C. Journal of Enzyme Inhibition and Medicinal Chemistry 26(2):176−80 doi: 10.3109/14756366.2010.486795 |
| [31] |
Song CQ, Zhang N, Xu RS, Song GQ, Sheng Y, et al. 1982. Studies on the antibacterial constituents of the leaves of Acer ginnala Maxim. II. isolation and identification of Ginnalin B, Ginnalin C and other six compounds. Acta Chimica Sinica 40(12):1142−47 |
| [32] |
Wang HY, Huang JZ. 2004. Gaocha: a new type of health drink. Journal of Tea Business 26(2):80−81 |
| [33] |
Kiss JP, Vizi ES. 2001. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends in Neurosciences 24(4):211−15 doi: 10.1016/S0166-2236(00)01745-8 |
| [34] |
Moncada S, Higgs A. 1993. The L-arginine-nitric oxide pathway. The New England Journal of Medicine 329(27):2002−12 doi: 10.1056/NEJM199312303292706 |
| [35] |
Bredt DS, Snyder SH. 1994. Nitric oxide: a physiologic messenger molecule. Annual Review of Biochemistry 63:175−95. doi: 10.1146/annurev.bi.63.070194.001135 |
| [36] |
Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF, et al. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Journal of Neurochemistry 64(2):936−39 doi: 10.1046/j.1471-4159.1995.64020936.x |
| [37] |
Mitchell GF. 2009. Arterial stiffness and wave reflection: Biomarkers of cardiovascular risk. Artery Research 3(2):56−64 doi: 10.1016/j.artres.2009.02.002 |
| [38] |
Ahmed HMMS, Youssef M, Mosaad YM. 2010. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clinical Rheumatology 29(11):1237−43 doi: 10.1007/s10067-010-1436-0 |
| [39] |
Han SS, Lo SC, Choi YW, Baek SH. 2004. Antioxidant Activity of Crude Extract and Pure Compounds of Acer ginnala Max. Journal of Molecular & Cellular Cardiology 25(3):389−91 doi: 10.5012/bkcs.2004.25.3.389 |
| [40] |
Chung JS, Lee MS, Chung JY. 2001. Antioxidative activity of the extracts from the leaves and fruits of Acer ginnala. Natural Product Sciences 7:45−48 |
| [41] |
Conway DE, Coon BG, Budatha M, Arsenovic PT, Orsenigo F, et al. 2017. VE-Cadherin Phosphorylation Regulates Endothelial Fluid Shear Stress Responses through the Polarity Protein LGN. Current Biology 27(14):2219−2225.E5 doi: 10.1016/j.cub.2017.06.020 |
| [42] |
Clarke NE, Turner AJ. 2012. Angiotensin-converting enzyme 2: the first decade. International Journal of Hypertension 2012:307315 doi: 10.1155/2012/307315 |
| [43] |
Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, et al. 2005. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605−10 doi: 10.1161/CIRCULATIONAHA.104.510461 |
| [44] |
Aldiwani H, Mahdai S, Alhatemi G, Bairey Merz CN, et al. 2021. Microvascular Angina: Diagnosis and Management. European Cardiology 16:e46 doi: 10.15420/ecr.2021.15 |
| [45] |
Wu C, Decker ER, Blok N, Bui H, You TJ, et al. 2004. Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonist. Journal of Medicinal Chemistry 47(8):1969−86 doi: 10.1021/jm030528p |
| [46] |
Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, et al. 2008. Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. The American Journal of Clinical Nutrition 88(4):1018−25 doi: 10.1093/ajcn/88.4.1018 |
| [47] |
Gerritsen ME. 1987. Functional heterogeneity of vascular endothelial cells. Biochemical Pharmacology 36(17):2701−11 doi: 10.1016/0006-2952(87)90252-8 |
| [48] |
Jelinic M, Jackson KL, O'Sullivan K, Singh J, Giddy T, et al. 2023. Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries. Life Sciences 320:121542 doi: 10.1016/j.lfs.2023.121542 |
| [49] |
Ulpiano Trillig A, Damianaki A, Hendriks-Balk M, Brito W, Garessus J, et al. 2023. Determinants of Renal Micro-Perfusion as Assessed with Contrast-Enhanced Ultrasound in Healthy Males and Females. Journal of Clinical Medicine 12(12):4141 doi: 10.3390/jcm12124141 |